Evidence map›Paper›PMID 36140150›Full record

ArticleBiosensors2022

Üzeyir Dogan, Ferah Sucularlı, Ender Yildirim, Demet Cetin, Zekiye Suludere, Ismail Hakkı Boyaci, Ugur Tamer

Open access · goldAbstract read
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Recent Advancements in the SERS-Based Detection ofSensors (Basel, Switzerland) · 2026
    Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Üzeyir DoganDepartment of Analytical Chemistry, Faculty of Pharmacy, Düzce University, 81620 Düzce, Türkiye.
Ferah SucularlıAselsan A.Ş., Radar, Electronic Warfare Systems Business Sector, 06172 Ankara, Türkiye.
Ender YildirimDepartment of Mechanical Engineering, Faculty of Engineering, Middle East Technical University, Çankaya, 06800 Ankara, Türkiye.ORCID 0000-0002-7969-2243
Demet CetinDepartment of Mathematics and Science Education, Gazi Faculty of Education, Gazi University, Besevler, 06500 Ankara, Türkiye.ORCID 0000-0003-1186-4229
Zekiye SuludereDepartment of Biology, Faculty of Science, Gazi University, Besevler, 06500 Ankara, Türkiye.ORCID 0000-0002-1207-5814
Ismail Hakkı BoyaciDepartment of Food Engineering, Hacettepe University, Beytepe, 06800 Ankara, Türkiye.ORCID 0000-0003-1333-060X
Ugur TamerDepartment of Analytical Chemistry, Faculty of Pharmacy, Gazi University, Etiler, 06330 Ankara, Türkiye.ORCID 0000-0001-9989-6123
Gazi University · TRAselsan (Turkey) · TRDüzce Üniversitesi · TRHacettepe University · TRMiddle East Technical University · TR

Funding

Gazi University Gazi BAP, project number 02/2018-08
6 · The paper itself

Abstract

Pathogen detection is still a challenging issue for public health, especially in food products. A selective preconcentration step is also necessary if the target pathogen concentration is very low or if the sample volume is limited in the analysis. Plate counting (24-48 h) methods should be replaced by novel biosensor systems as an alternative reliable pathogen detection technique. The usage of a capillary-driven microfluidic chip is an alternative method for pathogen detection, with the combination of surface-enhanced Raman scattering (SERS) measurements. Here, we constructed microchambers with capillary microchannels to provide nanoparticle-pathogen transportation from one chamber to the other.

Indexed as

Escherichia coliMetal NanoparticlesAdenosine TriphosphateGoldMicrofluidicsSpectrum Analysis, RamanStaphylococcus aureusAdenosine TriphosphateGoldEscherichia coligold nanorodsmagnetic separationmicrofluidic chipSERS detection

Identifiers

PMID36140150
PMCPMC9497094
OpenAlexW4296307200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.